Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends winning streak as pound rises, virus fears persist

Thu, 13th Feb 2020 08:58

* FTSE 100 down 1.1%, FTSE 250 down 0.6%

* Centrica, Barclays drag on main index

* Number of coronavirus cases in China rises

* Exporters hurt by a stronger pound
(Adds news items, analyst comments, closing prices)

By Shashwat Awasthi and Noor Zainab Hussain

Feb 13 (Reuters) - London's blue-chip index fell on Thursday
after two successive days of gains, dragged down by exporters
which were hurt by a stronger pound as investors positioned for
a higher-spending budget next month under a new British finance
minister.

The FTSE 100 ended the session 1.1% lower, derailed
by steep falls in heavyweights Barclays and Centrica
, while a rise in new coronavirus cases in China jolted
broader risk sentiment.

British utility Centrica skidded 15.3% after its 2019 profit
slumped by more than a third, while Barclays slipped 1.7% as
news Britain's financial regulators were probing historical
links between the bank's chief executive officer and U.S.
financier Jeffrey Epstein overshadowed financial results.

The mid-cap FSTE 250 lost 0.6%, tracking a broader
risk-off sentiment as the Chinese province of Hubei, an
epicentre of the coronavirus outbreak, reported a record rise in
deaths and thousands of more cases.

The increase in numbers, which came after China introduced a
new diagnostic procedure involving quicker computerised
tomography (CT) scans to screen patients, dented hopes that the
outbreak would soon plateau.

After the initial outbreak roiled global markets last month,
investors have become more sensitive to the rate of escalation.

"China is the world’s largest importer of oil so the renewed
fears about the health crisis have hit stocks like BP and Royal
Dutch Shell," CMC Markets analyst David Madden said, adding that
mining stocks such as BHP, Rio Tinto and Anglo
American were hurt too.

"It has been a double whammy for the FTSE 100 as the drive
higher in sterling has dented internationally focused stocks
like GlaxoSmithKline and AstraZeneca, plus
Unilever," he said.

The midcap index was also dragged down by British gambling
firms William Hill, GVC, Playtech and
888 following a media report that the gambling
commission would consider putting limits on the amount consumers
are allowed to bet online.

All sectors of the FTSE 100 ended lower, with oil majors
Shell and BP among the major drags, followed by
financials. The index substantially underperformed the broader
European benchmark as more of its components are
exposed to commodity prices.

UAE-based NMC Health, whose shares have swung
sharply in recent sessions amid takeover chatter, tumbled 4.2%
after analysts at SocGen slapped a double rating downgrade on
the stock.

Coca Cola HBC outperformed with a 3.6% gain after
it, along with fellow bottler Coca-Cola European Partners
, reported a higher annual profit.

Small-cap drugmaker Indivior fell more than 19%
after it reported a fourth-quarter loss.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Arun
Koyyur and Shounak Dasgupta and Kirsten Donovan)

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.